The average one-year price target for Emergent BioSolutions (NYSE:EBS) has been revised to $12.24 / share. This is a decrease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results